Julie So-Young Kim sold $1.5M of Takeda Pharmaceutical Company Limited (TAK)

Executed Aug 10, disclosed Aug 13, 2 days later.

Value, as filed

$1.5M

89,090 sh × $17.10

Executed

Aug 10

the trade date, as filed

Disclosed

Aug 13

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Julie So-Young Kim President and CEO profile →

Julie So-Young Kim (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Takeda Pharmaceutical Company Limited (TAK). The largest single filing was $1.5M of TAK (89,090 sh × $17.10, as filed), executed Aug 10.

The name

TAK

Takeda Pharmaceutical Company Limited TAK · Healthcare · 19 filings in 24 months ticker →

Healthcare · Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical pro…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→